Jbs Misses Q3 2026 Estimates as Revenue Falls 81% to $4.35B

Jbs (JBS) missed estimates for the third quarter of 2026 on both revenue and adjusted EPS. Revenue was $4.35 billion, down 81% from a year earlier, below the $22.85 billion estimate, and adjusted EPS was $0.16, down 69% from a year earlier, below the $0.21 estimate.

Shares fell 6.8% in after-hours trading as of 4:43 p.m. ET, to $12.23 from a $13.12 close.

Q3 2026 scorecard

By our calculation, revenue was $18.51 billion below the estimate and adjusted EPS was $0.05 below it. The QoQ column compares with the previous quarter's revenue of $23.90 billion and adjusted EPS of $0.20. The YoY column compares with $22.60 billion and $0.52 in the same quarter a year earlier.

Track record

• EPS record. Adjusted EPS beat the estimate in 3 of the last 8 reports, including this one.
• Revenue record. Revenue beat the estimate in 4 of the last 8 reports.
• Revenue trend. Revenue over the last 5 reports, oldest first: $22.60 billion, $23.06 billion, $21.61 billion, $23.90 billion and $4.35 billion.

What to watch

• Next-quarter estimates. Consensus calls for EPS of $1.90 and revenue of $126.6 billion next quarter, based on 3 analysts.
• Revenue growth. Whether revenue stabilizes after this quarter's 81% decline from a year earlier to $4.35 billion.
• Estimate record. Whether Jbs returns to beating EPS estimates, which it did in 3 of its last 8 reports.
• Related coverage. See our reports on Tidewater, Plug Power, AbCellera Biologics and USA Rare Earth.

Sources: Results are from Jbs's Nov. 9, 2026 quarterly report. Estimates are consensus figures. The prior-quarter and year-ago comparison figures are from Jbs's earlier quarterly reports. Items labeled by our calculation are our own arithmetic. This article is informational only and is not investment advice.